24 June 2015
("Instem" or "the Company")
Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces it will be holding a teach-in for investors and analysts on Tuesday, 14th July 2015.
The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 4.30pm.
A presentation will be given by the Instem management team, CEO, Phil Reason, and CFO, Nigel Goldsmith, for approximately one hour. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. No new material financial information will be disclosed. This will be followed by light refreshments and an opportunity to network.
To register for the event, please email firstname.lastname@example.org or call the Walbrook PR team below.
For further information, please contact:
|Phil Reason, CEO||+44 (0) 1785 825600|
|Nigel Goldsmith, CFO|
|N+1 Singer (Nominated Adviser & Broker)||+44 (0) 20 7496 3000|
|Wallbrook Financial PR||Tel: +44 (0) 20 7933 8000|
|Paul Cornelius||or email@example.com|
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidlyexpanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
To learn more about Instem solutions and its mission, please visit instem.com.